Taken together, our data demonstrates that vvDD-IL-2-FG and vvDD-IL-2-RG effectively maintains the IL-2 in the tumour microenvironment (Fig. 1d), and are, therefore, far safer than vvDD-IL-2. This evidence concerns the gene IL2 and neoplasm.